Author： Rinfret Stéphane
Publisher： Adis International
ISSN： 1175-3277
Source： American Journal of Cardiovascular Drugs, Vol.6, Iss.3, 2006-01, pp. : 159-168
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Sirolimus-eluting stent continues to impress in complex patients
Inpharma, Vol. 1, Iss. 1513, 2005-01 ,pp. :
Access to resources
Recommend
Cost-effectiveness of sirolimus-eluting stents in AMI `debatable'
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 583, 2009-01 ,pp. :
Sirolimus-eluting stent superior in diabetes
Inpharma, Vol. 1, Iss. 1461, 2004-01 ,pp. :
Paclitaxel-eluting stent rises to the challenge in high-risk patients
Inpharma, Vol. 1, Iss. 1483, 2005-01 ,pp. :
SES cost effective in high-risk patients in Canada
Inpharma, Vol. 1, Iss. 1551, 2006-01 ,pp. :